Friday, June 19, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 892 of 1,261

  1. US 8337839

    High affinity human antibodies to human IL-4 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  2. US 8337815

    Pulmonary surfactant formulations

    Discovery Laboratories, Inc. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  3. US 8337896

    Drug-containing nanoparticles

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  4. US 8338102

    Method of diagnosing poor survival prognosis colon cancer using miR-181b

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  5. US 8338104

    Method of diagnosing poor survival prognosis colon cancer using miR-103-2

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  6. US 8338107

    Method for producing polymers having a preselected activity

    CATALYST ASSETS, LLC · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  7. US 8337813

    Contrast agents

    Northwestern University · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  8. US 8337848

    Monoclonal antibody for APP

    University College Cardiff Consultants Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  9. US 8337854

    Monoclonal antibodies against dengue and other viruses with deletion in Fc region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  10. US 8337860

    Development of dengue virus vaccine components

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  11. US 8337866

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia

    The Regents of the University of California · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  12. US 8337831

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  13. US 8337853

    Monoclonal antibodies that bind or neutralize dengue virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  14. US 8337830

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  15. US 8337832

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  16. US 8338632

    Cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  17. US 8338173

    Preparation of antigen-presenting human γδ T cells and use in immunotherapy

    University College Cardiff Consultants Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  18. US 8338136

    Method of producing a paralytic peptide

    Soricimed Biopharma Inc. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  19. US 8338545

    Multi-arm block copolymers as drug delivery vehicles

    Nektar Therapeutics · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  20. US 8338597

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  21. US 8338366

    Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

    The Board of Regents of the University of Texas System · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  22. US 8338106

    Method of diagnosing poor survival prognosis colon cancer using miR-29a

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  23. US 8338105

    Method of diagnosing poor survival prognosis colon cancer using miR-203

    The United States of America as represented by the Secretary of the Department of Health and Human Services, National Institute of Health, Office of Technology Tansfer · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  24. US 8338103

    Method of diagnosing poor survival prognosis colon cancer using miR-106a

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.